Francisco Vallejo-Bedia

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Ejection Fraction

Duchenne Muscular Dystrophy

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Jessica Stoodley, Francisco Vallejo-Bedia, David Seone-Miraz, Manuel Debasa-Mouce, Matthew J A Wood, Miguel A Varela
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. International journal of molecular sciences 24 (3) (2023)
Jessica Stoodley, Francisco Vallejo-Bedia, David Seone-Miraz, Manuel Debasa-Mouce, Matthew J A Wood, Miguel A Varela
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. International journal of molecular sciences 24 (3) (2023)
Jessica Stoodley, Francisco Vallejo-Bedia, David Seone-Miraz, Manuel Debasa-Mouce, Matthew J A Wood, Miguel A Varela
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. International journal of molecular sciences 24 (3) (2023)
Jessica Stoodley, Francisco Vallejo-Bedia, David Seone-Miraz, Manuel Debasa-Mouce, Matthew J A Wood, Miguel A Varela
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. International journal of molecular sciences 24 (3) (2023)
Jessica Stoodley, Francisco Vallejo-Bedia, David Seone-Miraz, Manuel Debasa-Mouce, Matthew J A Wood, Miguel A Varela
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. International journal of molecular sciences 24 (3) (2023)